Literature DB >> 11286526

Assessing the effect of exercise training in men with heart failure; comparison of maximal, submaximal and endurance exercise protocols.

A I Larsen1, T Aarsland, M Kristiansen, A Haugland, K Dickstein.   

Abstract

AIMS: No consensus exists regarding the most appropriate exercise testing protocol for patients with congestive heart failure. This study describes the effect of exercise training on performance using three different protocols (maximal, submaximal and endurance testing) in patients with heart failure. METHODS AND
RESULTS: Thirty men (mean age 67+/-8 years) with congestive heart failure in NYHA class III (mean ejection fraction 32+/-5%) were evaluated prior to and following exercise training. A maximal exercise cycle test with gas exchange measurements, a submaximal 6 min walk test and an endurance treadmill test with blood lactate sampling were used to evaluate exercise capacity after 12 weeks of exercise training. There was a 44.6% (P<0.001) increase in work performed during the maximal cycle test, with no significant increase in peak VO(2). The distance covered by the submaximal 6 min walk test increased by 8.1% (P<0.001). Lactate measured as area under the curve during the matched work intensity treadmill endurance test was reduced by 19.5% (P<0.005).
CONCLUSION: We demonstrated a significant improvement in maximal, submaximal and endurance exercise capacity following 12 weeks of exercise training in patients with congestive heart failure. Endurance tests may be more sensitive and appropriate when assessing the efficacy of intervention in this population. Specifically, demonstration of reduced lactate production at matched work intensities suggests more efficient work and decreased dependence on anaerobic metabolism following training. Although maximal cycle tests are commonly used in clinical work, submaximal and endurance testing might be preferable for evaluating new treatment regimens in this population as they are easy to perform, are reproducible, and reflect daily tasks better than the maximal cycle test in this population. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286526     DOI: 10.1053/euhj.2000.2286

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

1.  Peak oxygen uptake. Myth and truth about an internationally accepted reference value.

Authors:  T Meyer; J Scharhag; W Kindermann
Journal:  Z Kardiol       Date:  2005-04

2.  A pilot study to assess the feasibility of a submaximal exercise test to measure individual response to cardiac medication in dogs with acquired heart failure.

Authors:  L Ferasin; S Marcora
Journal:  Vet Res Commun       Date:  2007-01-25       Impact factor: 2.459

3.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

Authors:  Tina Dysgaard Jeppesen; Bjørn Quistorff; Flemming Wibrand; John Vissing
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

4.  Association between hyperlactatemia and occult cardiac failure in diabetic patients on maintenance hemodialysis.

Authors:  Umut Varol; Yelda Varol; Mustafa Yaprak; Atilla Uzum; Mustafa Cirit
Journal:  Int Urol Nephrol       Date:  2013-12-20       Impact factor: 2.370

5.  The role of exercise therapy in the treatment of patients with systolic heart failure.

Authors:  Andrew Kao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

6.  Effectiveness of a physiotherapeutic exercise programme for chronic heart failure patients.

Authors:  I J M Scheffers; J M Orbons-Cartigny; G Jansen; G S J T de Bruijn; R Vesters; J G Meeder
Journal:  Neth Heart J       Date:  2004-02       Impact factor: 2.380

Review 7.  Exercise programmes for patients with chronic heart failure.

Authors:  Tim Meyer; Michael Kindermann; Wilfried Kindermann
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Oxygen uptake kinetics in chronic heart failure: clinical and physiological aspects.

Authors:  H M C Kemps; G Schep; J Hoogsteen; E J M Thijssen; W R De Vries; M Zonderland; P Doevendans
Journal:  Neth Heart J       Date:  2009-06       Impact factor: 2.380

9.  Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study.

Authors:  Michael M Givertz; Douglas L Mann; Kerry L Lee; Jenny C Ibarra; Eric J Velazquez; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2013-07       Impact factor: 8.790

10.  Resistance exercise enhances oxygen uptake without worsening cardiac function in patients with systolic heart failure: a systematic review and meta-analysis.

Authors:  Francisco V Santos; Gaspar R Chiappa; Sergio Henrique Rodolpho Ramalho; Alexandra Correa Gervazoni Balbuena de Lima; Fausto Stauffer Junqueira de Souza; Lawrence P Cahalin; João Luiz Quagliotti Durigan; Isac de Castro; Gerson Cipriano
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.